Therapeutic safety implications of SARM1 active site inhibitors: subinhibitory concentrations cause neurodegeneration.
- DOI
- 10.1038/s44386-025-00023-4
- Published
- 2025 Aug 25
- Container
- npj drug discovery
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s44386-025-00023-4,
title = {Therapeutic safety implications of SARM1 active site inhibitors: subinhibitory concentrations cause neurodegeneration.},
author = {Leahey RR and Weber M and Cho CH and Hur SK and Cramer A and Manzanares K and Babin B and Boenig G and Kring T and Liu L and Cui Y and Ganti A and Evans JP and Nespi M and Ly J and Nugent AA and Green SA and Chan BK and Hoogenraad CC and Delwig A and Hinz FI},
year = {2025},
journal = {npj drug discovery},
doi = {10.1038/s44386-025-00023-4},
url = {https://doi.org/10.1038/s44386-025-00023-4}
}RIS
TY - JOUR TI - Therapeutic safety implications of SARM1 active site inhibitors: subinhibitory concentrations cause neurodegeneration. AU - Leahey RR AU - Weber M AU - Cho CH AU - Hur SK AU - Cramer A AU - Manzanares K AU - Babin B AU - Boenig G AU - Kring T AU - Liu L AU - Cui Y AU - Ganti A AU - Evans JP AU - Nespi M AU - Ly J AU - Nugent AA AU - Green SA AU - Chan BK AU - Hoogenraad CC AU - Delwig A AU - Hinz FI PY - 2025 JO - npj drug discovery DO - 10.1038/s44386-025-00023-4 UR - https://doi.org/10.1038/s44386-025-00023-4 ER -
APA
RR, L., M, W., CH, C., SK, H., A, C., K, M., B, B., G, B., T, K., L, L., Y, C., A, G., JP, E., M, N., J, L., AA, N., SA, G., BK, C., CC, H., A, D., & FI, H. (2025). Therapeutic safety implications of SARM1 active site inhibitors: subinhibitory concentrations cause neurodegeneration.. npj drug discovery. https://doi.org/10.1038/s44386-025-00023-4
Source records
- pubmed · retrieved 2026-09-26T12:34:54.628Z